Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ergots, ergot alkaloids, ergolines

4

V.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

3
Last update : 07/05/2019
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Bromocriptine
3
Cabergoline
3
Dihydroergocristine
1
Dihydroergocryptine
1
Dihydroergotamine
1
Ergonovine
1
Ergotamine
2
Methysergide
2
Nicergoline
1
Pergolide
3

Publications

[Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
Archivos de bronconeumologia 2009 Feb;45;100-2 2009 Feb
Pleuropulmonary changes induced by ergoline drugs.
The European respiratory journal 1996 May;9;1013-9 1996 May
Pleural effusion and fibrosis secondary to Sansert administration.
The Annals of thoracic surgery 1973 Mar;15;295-8 1973 Mar

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies